Tuesday, March 04, 2025 | 10:15 PM ISTहिंदी में पढें

Home / Companies / Results / Dr Reddy's Q1 PAT falls 13% to Rs 579 cr, revenue up by 15% to Rs 4,417 cr

Dr Reddy's Q1 PAT falls 13% to Rs 579 cr, revenue up by 15% to Rs 4,417 cr

Commenting on the results, co-chairman and MD, G V Prasad said "the current quarter's financial performance has been strong across all parameters

Premium

Revenues for the quarter under discussion was up by 15per cent to Rs 4,417.5 crore against Rs 3,843.5 crore in Q1 of last fiscal

Press Trust of India Hyderabad

2 min read Last Updated : Jul 29 2020 | 3:45 PM IST

Dr Reddys Laboratories Limited's consolidated profit after tax for the quarter ended June 30 was down by 13 per cent to Rs 579.3 crore against Rs 662.8 crore during the same quarter in FY20, the company said in filing with stock exchanges on Wednesday.

Revenues for the quarter under discussion was up by 15per cent to Rs 4,417.5 crore against Rs 3,843.5 crore in Q1 of last fiscal, it said.

Commenting on the results, Co-chairman and MD, G V Prasad said "the current quarter's financial performance has been strong across all parameters.

I am glad that we have been able

Topics : Dr Reddy's Pharma Companies

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in